Cerebral Small Vessels Disease Terminated Phase 3 Trials for Telmisartan (DB00966)

Also known as: Cerebral Small-vessel Disease / Cerebral Small Vessel Disease / Cerebral Small Vessel Diseases / Cerebral microangiopathy / Small vessel cerebrovascular disease (disorder) / Cerebral small vessel ischaemic disease / Cerebral small vessel ischemic disease

IndicationStatusPhase
DBCOND0072196 (Cerebral Small Vessels Disease)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03785067
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-StudyScreening